Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
national blog main
boston blog main
boston top stories
national top stories
san diego blog main
san diego top stories
san francisco blog main
acute myeloid leukemia
adverum biotechnologies
ambit biosciences
athena countouriotis
bill & melinda gates foundation
biobucks
biotech ipos
boston
brett zbar
bristol-myers squibb
calistoga pharmaceuticals
car-t immunotherapy
ceo
checkpoint inhibitors
clinical trials
co-founder
cormorant asset management
daiichi sankyo
disease
dyne therapeutics
fda
gates foundation
gilead sciences
halozyme therapeutics
hbm healthcare investments
hbm partners
health
healthcare
hiv
idelalisib
immuno-oncology
What
drug
4
×
million
4
×
therapeutics
4
×
raised
cancer
company
developing
new
acting
adding
aiming
athena
bets
biotech
boost
brings
ceo
change
chief
consumption
continue
countouriotis
creating
delayed
delivery
disorders
dyne
dyne’s
expensive
far
financing
genetic
gets
gilead
ipo
kind
little
long
lyndra
mecha
Language
unset
Current search:
drug
×
therapeutics
×
million
×
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@techcrunch.com
5 years ago
Aiming to change the way people take medicine, Lyndra Therapeutics raises $55 million
@xconomy.com
5 years ago
To Boost Cancer Pipeline, Gilead Bets at Least $50M on Startup Tango
@xconomy.com
5 years ago
TP Therapeutics Names New CEO, Gets $80M More For Cancer Drug Push